Treatment Name: Carboplatin + Paclitaxel (Carbo/Taxol®)
Carboplatin + Paclitaxel (Carbo/Taxol®) is a Chemotherapy Regimen for Uterine/Endometrial Cancer
How does carboplatin + paclitaxel work?
Both carboplatin and paclitaxel are chemotherapy drugs designed to kill and slow the growth of cancer cells.
Goals of therapy:
Carboplatin + paclitaxel (also known as Carbo/Taxol) may be given with the goal of cure if the disease is not metastatic (spread to other areas of the body). If the disease is metastatic, it may be given to decrease the symptoms of uterine cancer and prolong life.
- Carboplatin intravenous (I.V.) infusion over 30 to 60 minutes on Day 1
- Paclitaxel I.V. infusion over 3 hours on Day 1
Estimated total infusion time for this treatment:
- Plan for at least 5 hours or longer for your chemotherapy drug infusion appointments
- Infusion times are based on clinical studies, but may vary depending on doctors’ preferences or patients’ tolerability. Pre-medications to prevent nausea or allergic reactions and I.V. fluids (e.g., hydration or electrolytes) may add more time to your infusion appointment
Carboplatin + paclitaxel is typically repeated every 21 days. Each 21-day course is referred to as one Cycle of chemotherapy. The number of cycles you receive is dependent on your cancer stage, tolerability of treatment, and response to treatment.
Click here for the common carboplatin + paclitaxel starting doses.
In a multi-drug regimen, each medicine has unique side effects. When these medicines are given together, drug-related side effects reported in clinical studies give the best estimate of what to expect. In clinical studies, often only the most severe side effects from carboplatin + paclitaxel are shown here. Side effects sometimes have percentage ranges [example: 36 – 79%] because they differed between clinical studies:
Allergic reactions to either carboplatin or paclitaxel infusions are possible. Due to restriction of side effects to only those that were considered more severe, some known side effects of carboplatin + paclitaxel were not reported in clinical studies.
Approximately 12% of patients discontinue treatment due to unacceptable chemotherapy drug side effects.
How often is monitoring needed?
Labs (blood tests) may be checked before each treatment and periodically during each cycle. Labs often include: Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), plus any other labs your doctor may order.
How often is imaging needed?
Imaging may be checked before treatment and periodically during and after treatment. Imaging may include: computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET) scans, or X-rays.
How might blood test results/imaging affect treatment?
Depending upon the results, your doctor may advise to continue carboplatin + paclitaxel as planned, or delay or switch therapy.
- Paclitaxel tends to cause infusion reactions that can be related to the cremophor that is used in the IV formulation. Patients may receive several medications prior to receiving paclitaxel (this is known as "pre-medication") to decrease the risk of infusion reactions. Common pre-medications given are a histamine-2 blockers such as famotidine (Pepcid®) or ranitidine (Zantac®), a histamine-1 blocker such as diphenhydramine (Benadryl®), and a corticosteroid such as dexamethasone
- Carboplatin hypersensitivity reaction can be severe. This reaction is most common around the 8th or 9th cycle, but can happen after any dose. Some institutions may use "desensitization protocols" to allow a person to keep receiving carboplatin after they have had a reaction. Desensitization is used if someone is receiving a good response from carboplatin, or if few other chemotherapy options are available
- Patients and their caregivers should be counseled to recognize the signs and symptoms of drug reactions and reports them immediately, even after they have left the clinic
- A pharmacist should ALWAYS review your medication list to ensure that drug interactions are prevented or managed appropriately
- Clinical trials may exist for uterine/endometrial cancer. Ask your doctor if any studies are currently enrolling in your area. If not, go to clinicaltrials.gov to search for other centers offering study medications
Patient Assistance & Co-payment Coverage
Patients under the age of 65 years, or those with private insurance plans:
If you have insurance and are looking for patient assistance or copay assistance for Carboplatin + Paclitaxel (Carbo/Taxol®), we have provided links that may help.
Visit our Patient Assistance page and click the links to various patient assistance programs for help paying for Carboplatin + Paclitaxel (Carbo/Taxol®). Depending upon your income, they may be able to help cover the cost of:
For Branded medications (may be available for generic medications too), check with the manufacturer to determine if a co-pay card is offered and if it could reduce your monthly copay.
- If you are uninsured, check with the manufacturer to determine if you are eligible to receive medication at no cost.
Medicare and Medicaid patients (Patients 65 years or older):
The clinic providing treatment will likely pre-authorize medications and immune therapies such as Carboplatin + Paclitaxel (Carbo/Taxol®) and are the best source to help you understand drug cost.
- Ask to speak with a patient assistance technician or financial counselor at the clinic or hospital administering this therapy.
What is Emotional Wellness?
Emotional wellness is having a positive outlook balanced with a realistic understanding of current life events. This requires both an awareness and acceptance of your emotions. It is with this knowledge that you can develop a plan to take the necessary actions to positively impact your life.
Emotional wellness uses an ongoing process to continually reflect on the stressors of life in a constructive manner to move forward and create happiness.
Because emotional wellness is deeply connected with physical, social, and spiritual wellness, pursuing it often becomes particularly difficult in times of major illness. Despite this difficulty, working toward emotional wellness has been connected to improved treatment outcomes and a higher likelihood of achieving goals of therapy.
Learn more about pursuing emotional wellness while receiving treatment with Carboplatin + Paclitaxel (Carbo/Taxol®)
What is Uterine/Endometrial Cancer?
A disease of the cells found in the lining of the uterus, also known as the endometrium, in women. Uterine cancer (also referred to as endometrial cancer) is the most common gynecologic cancer. The exact cause is not known, however risk factors may include: older age, obesity, metabolic syndrome, taking tamoxifen, taking estrogen hormone replacement therapy without progesterone after menopause, type 2 diabetes, never becoming pregnant, having your first menstrual cycle at a young age, undergoing menopause at an older age, polycystic ovarian syndrome, family history uterine cancer, Lynch syndrome, and endometrial hyperplasia.
The stage of uterine cancer can vary at diagnosis and throughout treatment. Uterine cancer is staged using the Tumor, Node, Metastasis (TNM) staging system, as well as Stage Grouping I, II, III, or IV. Staging systems describe the extent of cancer throughout the body and help doctors determine which treatments to offer. The effectiveness of the treatment may depend upon the stage at diagnosis.
NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.
What does Cure mean?The word “cure” means there are no cancer cells left in the body and cancer will never come back. Depending on the cancer type and stage, this may be the true goal of therapy. However, it is very difficult to prove all cancer cells are gone. Even though images, like X-rays and MRI’s, and blood tests may not show any signs of cancer, there can be a small amount of cancer cells still left in the body. Because of this, the word “remission” is used more often. This means there are no signs or symptoms of cancer. Patients in remission are followed closely for any signs of cancer returning. Sometimes, more chemotherapy may be given while in remission to prevent the cancer from coming back.
Doctors usually do not consider a patient “cured” until the chance of cancer returning is extremely low. If cancer does return, it usually happens within 5 years of having a remission. Because of this, doctors do not consider a patient cured unless the cancer has not come back within 5 years of remission. The five-year cutoff does not apply to all cancers.
Common starting doses
- Carboplatin AUC 5 intravenous (I.V.) infusion over 30 to 60 minutes on Day 1
- Paclitaxel 175 mg/m2 I.V. infusion over 3 hours on Day 1
Note: Individual doses may vary based upon your Doctor's recommendation, or drug availability.
1) Miller D, Filiaci V, Fleming G, et al. Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 2012;125:771-773.
2) Pectasides D, Xiros N, Papaxoinis G, et al. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer. Gynecologic Oncology. 2008;109:250-254.
What is a CBC?
A Complete Blood Count (CBC) is a frequently ordered blood test that tells clinicians the status of your: 1) White blood cell count, 2) Hemoglobin, and 3) Platelet count at the time the test was taken.
1) White blood cell count (WBC): is used to determine infection risk, or response to chemotherapy. Certain chemotherapy agents may harm our good infection-fighting cells. Sometimes chemotherapy may need to be delayed to allow these cells to recover.
2) Hemoglobin: is used to determine if someone is anemic. Anytime the hemoglobin is below 12 g/dL, the person is said to be anemic. Red blood cell transfusions, and sometimes iron can be given to restore the hemoglobin level, but anemia treatment should always aim at treating the underlying cause or condition.
3) Platelet count: is used to determine if the risk of bleeding is increased or if a platelet transfusion is required to prevent bleeding. Certain medications that increase bleeding risk, such as: aspirin, certain chemotherapy agents, and blood thinners, may need to be stopped temporarily until the platelet count is within a safe range.
What is a CMP?
A Comprehensive Metabolic Panel (CMP) is a frequently ordered blood test that tells clinicians the status of your: 1) Electrolytes & Acid/Base status, 2) Kidney function, 3) Liver function, 4) Blood sugar, and 5) Calcium at the time the test was taken. It is commonly used to monitor liver and kidney function when beginning new medications such as chemotherapy. A total of 14 tests are run simultaneously and are shown below.
Electrolytes & Acid/Base status:
1) Sodium, 2) Potassium, 3) Carbon dioxide, 4) Chloride
5) BUN (blood urea nitrogen), 6) Serum creatinine (Scr)
7) AST, 8) ALT, 9) Total bilirubin, 10) Alk Phos, 11) Albumin, 12) Total protein
13) Serum glucose
14) Serum calcium